TScan Therapeutics, Inc., a biopharmaceutical company focused on the development of T-cell receptor engineered T cell therapies for the treatment of patients with cancer, announced that Gavin MacBeath, Ph.D., Chief Scientific Officer at TScan, will present the findings of TScan’s work to discover the targets of T cells in recovering COVID-19 patients at the Cell-Mediated Therapies for Infectious Disease Summit.
July 21, 2021
· 6 min read